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The objective of this project was to simplify peritoneal cavity access so an 
Airforce field medic can safely infuse oxygen microbubbles (OMBs) into the 
intraperitoneal space for the emergency treatment of hypoxia due to lung damage. To 
solve this problem, we created an intraperitoneal catheter placement device for use on the 
battlefield. The three common methods and some of the most common devices for 
peritoneal cavity access were reviewed. Injury frequencies for each of the three methods 
were analyzed. The results showed that each of the access techniques gives a similar rate 
of iatrogenic injury.  
The battlefield conditions where the device will be used were also researched. 
The intraperitoneal infusion of OMBs is most likely to occur at or following the tactical 
field care stage. A field medic’s bag can be large and heavy. Thus, the catheter placement 
device needed to be small and lightweight (< 1 kg). Also, since field medics do not 
receive as much training as surgeons do, the device insertion technique needed to be 
simple, have no requirement for advanced surgical training, and have a minimal chance 
for error.  
A major part of device development was a study to determine the optimal 
pressure range for initial insufflation of the peritoneal cavity. The study was performed 
 
 
on twelve fresh porcine carcasses to compare the minimum preperitoneal insufflation 
pressure and the minimum initial peritoneal cavity insufflation pressure. Pressures greater 
than 10 mmHg resulted in initial cavity insufflation and pressures greater than 20 mmHg 
resulted in preperitoneal insufflation in porcine models.  
Description of the first functioning prototype was set forth. A threaded trocar was 
used to control peritoneal cavity entrance. The threaded trocar was rotated by a hand 
crank that increased the ergonomics and speed of entry. A spring-loaded flexible pressure 
cylinder at 20 mmHg was used to inform the user when the peritoneal cavity was 
accessed. The applied pressure was low enough to not insufflate the abdominal wall 
during insertion. As soon as the cavity was reached, the pressure was sufficient to 
insufflate the cavity and the user was informed when to stop advancing the trocar. Thus, 
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Chapter 1 – First entry into the Peritoneal Cavity 
 
Peritoneal cavity access is essential in several medical procedures and surgeries. 
For example, intraperitoneal cavity infusion of oxygen microbubbles (OMBs) is a means 
of oxygenating the body when the lungs are not capable of doing so due to a variety of 
health issues (e.g., acute respiratory distress syndrome, smoke inhalation, or gunshot 
wound) [1]. To infuse the microbubbles, the peritoneal cavity must first be accessed, and 
a catheter must safely be placed within the cavity. There are current devices that can do 
this procedure under operating room conditions. However, for conditions outside the 
controlled environment of the hospital operating room (e.g., the battlefield), no devices 
have been developed or tested. Thus, the objective of this project was to develop a device 
that safely and reliably places a peritoneal catheter in battlefield conditions. The catheter 
could be used for the delivery and removal of oxygen microbubbles or for the injection of 
expansile foam to control severe bleeding and/or minimize contamination from intestinal 
injury in military or civilian settings. 
1.1 Peritoneal cavity access 
All laparoscopic procedures are first performed by making a small incision on the 
abdominal wall and by placing a needle or trocar into the peritoneal cavity (Figure 1). 
This first step can be the most complex part of the procedure and results in nearly 50% of 
all laparoscopic complications [2]. With over 13 million laparoscopic procedures 
performed globally and a primary access complication rate of around 1 in 1000, over 
13,000 complications occur per year [3], [4]. Physicians must be ever mindful during 
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initial entry as most life-threatening accidents to the great vessels or the intestines occur 
during initial access [5]. Accessing the peritoneal cavity can be justified for a variety of 
medical procedures including oxygen microbubble infusion, nephrectomy, hysterectomy, 
cholecystectomy, colectomy, bariatric surgery, adrenalectomy, anti-reflux, abdominal 
perineal resection, hernia repair, gastrectomy, and appendectomy [6]. 
 
Figure 1: Laparoscopic surgery diagram [7]. 
Accessing the peritoneal cavity can be difficult for a variety of reasons. The first 
and foremost reason is the elasticity of abdominal wall tissue. As a cutting force is 
applied to the tissue, it deflects until the force is great enough to incise the tissue. This 
deflection is known as tenting. The insertion force is counterbalanced by the tension 
within the tissue. The parietal peritoneum is the final layer of the abdominal wall and it is 
generally the most elastic, requiring the greatest cutting force. As soon as this last layer is 
breached, there is a brief instant where the insertion force is still applied but the tension 
force from the tissue is no longer present. This offset of forces creates a plunge into the 
peritoneal cavity which continues until the physician can properly react to the loss of 
tension.   
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Another side effect of tenting can be the “self-skewering” of organs [8]. When 
tenting occurs, the organs within the peritoneal cavity are also displaced to make room 
for the abdominal wall indent. As soon as the parietal peritoneum is breached, the 
abdominal wall springs back to its natural resting position. As this happens, the 
abdominal organs are drawn back with the abdominal wall towards the needle/trocar, 
which can result in visceral injury. In other words, even if the tip of the needle/trocar 
were not advancing further after reaching the cavity, the abdominal organs are drawn 
back towards the needle resulting in iatrogenic injury. Combining both consequences of 
tenting results in the physician momentarily pressing the needle/trocar into the abdominal 
organs and the abdominal organs being pulled into the needle. 
A final consequence of tenting is the minimization of the potential space of the 
peritoneal cavity. As the tissue is compressed, the underlying organs are also compressed, 
minimizing the space between the peritoneum and the viscera. As the potential space is 
minimized, the target tip depth becomes more difficult to achieve.  
Although it can be difficult to properly access the peritoneal cavity, several 
devices and techniques have been developed to minimize iatrogenic injury. There are 
three general access methods: closed laparoscopy, open laparoscopy, and direct trocar 
placement. No access method has consistently proven to be safer or more effective than 
another. The chosen method usually depends on surgeon preference or whether the 
patient has had previous abdominal surgeries [9], [10]. 
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1.2 Closed laparoscopy – the Veress needle 
Before the advent of the Veress needle in the late 1930s, initial access to the 
peritoneal cavity had generally been done by either blindly placing a standard needle into 
the cavity to create pneumoperitoneum or with a surgical cut-down to the peritoneum and 
needle placement under direct vision [6]. Since the 1930s, the Veress needle’s popularity 
among gynecologists grew and by the 2010s, it was considered the most popular tool for 
initial access [6]. Since its invention, the basic functional principles of the Veress needle 
have remained constant.  
Veress needles are typically 12-17 cm long and are composed of a 2 mm outer 
diameter hypodermic needle with a round, spring-loaded obturator in the center (Figure 
2). Ideally, as the Veress needle is placed through the abdominal wall, the obturator 
retracts to expose the hypodermic needle. Once the peritoneal cavity has been breached, 
the obturator is extruded, and the needle tip is protected. However, Veress needle 
placement is rarely considered perfect. Since it is a blind procedure, injuries still occur. 
To mitigate injuries during placement, several attempts to improve the Veress needle 
have been made. In 1994, a pressure sensor-equipped Veress needle was described [11]. 
The inventors of this enhanced Veress needle claimed the needle could detect the 
intraperitoneal position of the tip at the moment it entered the peritoneal cavity [11]. This 
was the start of what is known as the pressure profile test (discussed later). Today’s 
Veress needles do not have built-in pressure sensors, rather, insufflators are used for 




Figure 2: Diagram of the components of a standard Veress needle. Figure reproduced without alteration 
from [12]. 
Around the same time, another iteration on the Veress needle was made to create 
the optical Veress needle. For this needle, a 250 mm long fiber-optic cable was placed 
through the center of the needle cannula [13]. Rinsing through the cannula was permitted 
to clear the puncture tract by water dissection and to clean the cable tip [13]. By doing 
this, all layers of the abdominal wall and the time of peritoneum puncture could be 
visualized during insertion. However, the 2mm visual provided by the system was far 
inferior to that of endoscope capabilities, so the optical Veress needle never became 
widespread. As such, studies comparing the efficacy of the Veress needle to the optical 
Veress needle lack sufficient power [14]. As fiber-optic cameras continue to improve, 
enhanced versions of the optical Veress needle are being presented [15]–[17].  
1.2.1 Radially expanding trocar system 
A device that built upon the Veress needle is the radially expanding trocar system. 
For initial access, a standard Veress needle is used to access the cavity and establish 
pneumoperitoneum. The needle is then removed and a Veress needle coated with an 
expandable polymer sheath is inserted (Figure 3A). The needle is then removed, leaving 
the sheath in place. A blunt trocar and dilator are then inserted through the sheath to 
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expand and dilate the existing hole (Figure 3B). Thus, by using the existing hole, the 
tissue is stretched and separated rather than incised. After the hole has been expanded, the 
dilator is removed and the trocar is left in place for the subsequent laparoscopic 
procedure (Figure 3C) [18]. Studies have shown that by stretching instead of cutting the 
tissue, patient pain, recovery time, and procedure time have all been reduced while 
increasing patient safety [18]–[25].  
 
Figure 3: Radially expanding trocar system diagram. (A) The needle is inserted and removed leaving the 
expandable sleeve. (B) The blunt dilator and cannula are inserted. (C) The blunt dilator is removed leaving 
the cannula. Figure reproduced without alteration from [18]. 
1.2.2 Concomitant vs subsequent insufflation 
The primary purpose of using the Veress needle is to easily gain access to the 
peritoneal cavity. After placement of the needle, the cavity is insufflated with carbon 
dioxide (CO2) gas (pneumoperitoneum) to simplify placement of the subsequent trocars. 
Insufflation is typically started after confirmed needle placement (subsequent 
insufflation), but it can be done concomitantly. Concomitant insufflation is when the 
insufflation needle is inserted through the skin incision and into the peritoneal cavity 
while carbon dioxide flows through the needle [26]. If concomitant insufflation is paired 
with the pressure profile test (discussed later), then a pressure drop indicates the Veress 
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needle has breached the parietal peritoneum and has accessed the potential space of the 
peritoneal cavity [27]. A drawback to both subsequent and concomitant insufflation is 
preperitoneal insufflation, which can cause subcutaneous emphysema and access failure 
[28]. A recent clinical study compared both access techniques [26]. For this study, 
concomitant CO2 insufflation saw a higher placement success rate while both methods 
saw similar placement times [26]. 
1.2.3 Confirmation tests for the Veress needle 
Since the Veress needle is placed blindly, it is difficult for the physician to be 
100% certain the needle has been placed in the potential space of the peritoneal cavity. 
There are generally four tests that can be performed to help confirm correct placement. 
Each test may assist in placement confirmation, but none of them are foolproof [26]. To 
increase test efficacy, tests can be paired with each other (e.g., the double click test and 
Palmer’s test can both be performed) [29], [30]. A recent study showed that only the 
pressure profile test is effective at confirming correct placement [30]. 
1.2.3.1 Double click test 
  In this test, the physician listens for audible clicks or feels for haptic pulses as the 
Veress needle is inserted. If the needle is placed along the midline, then two clicks or 
pulses should be recognized: one for passing through the linea alba, and one for 
breaching the peritoneum. If the needle is placed off the midline (e.g., Palmer’s point), 
then theoretically three clicks or pulses should be recognized: one for both the anterior 
and posterior rectus sheaths, and one for breaching the peritoneum. As the tip of the 
needle penetrates these tougher tissue layers, the blunt obturator is retracted to expose the 
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sharp hypodermic needle. Immediately after the tissue is dissected, the obturator springs 
back to its natural state creating the haptic and audible clicks [29]–[31].  
1.2.3.2 Palmer’s test 
  Also known as the aspiration and irrigation test, this is the most widely used 
safety test. This test is performed in three stages. First, a 5 ml syringe with physiological 
saline is connected via a Luer lock to the top of the Veress needle. The syringe is then 
aspirated for blood. In the absence of fluid, the second step is to inject the contents of the 
syringe. The syringe should be easily depressed with little to no resistance. This confirms 
there are no adhesions, and the needle is not in contact with intra-abdominal viscera. The 
third and final step is to re-aspirate the syringe. Re-aspiration should not yield a return, as 
the saline should have spread throughout the peritoneal cavity. If any other fluid is 
aspirated, a laparotomy may be required [29]–[34].  
1.2.3.3 Hanging saline drop test 
To perform this test, a few drops of saline are placed in the Luer lock at the top of 
the Veress needle. The abdominal wall is then slightly lifted to create a vacuum in the 
peritoneal cavity. The fluid in the syringe should then move freely to the intraperitoneal 
space. If the fluid remains still, then there is likely an obstruction at the tip, indicating 
incorrect placement [29]–[31].  
1.2.3.4 Pressure profile test 
There are two different types of this test, one for each insufflation technique. For 
subsequent insufflation, the gas tubing is first primed to remove all air in the line. The 
tubing is then connected to the Veress needle and the flow rate is set to 1 L/min. Five 
pressure readings from the gas insufflator are then recorded every five seconds. All 
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pressure readings should be under 8-10 mmHg. If a single pressure reading is greater than 
this, then the needle is likely not in the intraperitoneal space. This test is effective 
regardless of age, BMI, and parity [35]–[38].  
When concomitant insufflation is used, the tubing is connected to the Veress 
needle before placement and the whole set is primed. With CO2 flow set to 1 L/min, the 
Veress needle is inserted through a skin incision. As the needle is slowly inserted through 
the abdominal wall, the insufflation pressure is continuously monitored. As soon as the 
insufflation pressure drops to below 8 mmHg, the peritoneal cavity has been accessed. In 
thin patients, it is recommended to lift the abdominal wall to increase the separation 
between the needle tip and major vessels [27].  
1.2.3.5 Micro-electrical impedance spectroscopy 
Another proposed method of confirming the correct placement of the Veress 
needle is micro-electrical impedance spectroscopy for depth profiling [39]. The 
researchers tested the electrical impedance of abdominal organs prone to iatrogenic injury 
and the peritoneal cavity in rats. The test results showed the resistance and compliance of 
the abdominal cavity compared to the abdominal organs were 4.8 times larger and 2.8 
times larger, respectively. Thus, the location of the needle tip could easily be identified, 
and placement efficacy might be improved. However, it is not clear how relevant the rat 
model is to the human abdomen for this application. 
1.3 Open laparoscopy 
In 1971, Harrith Hasson presented an alternate to Veress needle placement [40], 
[41]. He proposed a surgical cutdown at the umbilicus (minilaparotomy) to the 
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peritoneum. A blunt trocar, composed of a blunt obturator within the lumen of a large 
cannula, was then placed under direct vision through the peritoneum and into the 
peritoneal cavity. Blunt trocars (commonly call Hasson cannulas) include a conical 
shaped, adjustable plug on the outside of the trocar for sealing the incision (Figure 4). 
The plugs include suture tie posts to help keep the cannula in place during the 
laparoscopic procedure and to maintain a seal. The proposed advantages of this procedure 
include the ability to place the primary trocar under direct vision, the ability to place the 
trocar even with adhesions present, avoiding vascular injury, avoiding preperitoneal 
insufflation, and preventing gas embolisms [6]. Open laparoscopy is suggested for 
extremely thin patients, patients with umbilical adhesions or who have had previous 
laparoscopic procedures, pregnant women, and children [5]. The procedure, however, is 
more time consuming, is a more complex procedure, and is not appropriate for emergent 
or field conditions [42].  
 




1.4 Direct trocar placement 
 Placement of the trocar directly into the peritoneal cavity without previous 
pneumoperitoneum was conceived to avoid the injuries and negative results of Veress 
needle placement [44], [45]. Also, direct trocar entry generally requires less time to trocar 
placement than the use of a Veress needle. Direct entry has been performed using blunt 
(often called bladeless), bladed, and optical trocars.  
1.4.1 Blunt trocar placement 
Placing a blunt trocar directly into the peritoneal cavity blindly was first described 
in 1978 by Dr. James Dingfelder [45]. He questioned the assumption that 
pneumoperitoneum must first be established before trocar placement. He also sought to 
find a technique that avoided the common pitfalls of Veress needle placement (e.g., 
subcutaneous emphysema, omental emphysema, gas embolism, bowel distention, 
overdistention, and blood vessel penetration). He conducted a study with 301 outpatient 
laparoscopies using his new technique. Three complications were encountered: one 
uterine perforation and two cases requiring posthospitalization from vomiting and nausea. 
With the positive results, he concluded that direct trocar entry was feasible [45]. Since 
then, several studies have shown that a surgical cutdown to the peritoneum is not 
necessary to directly place a blunt trocar effectively [46]–[49]. Of the studies that had 
enough statistical power to draw conclusions, they found direct trocar placement to be 
both faster and safer than Veress needle placement.  
To place a blunt trocar, a skin incision is first made. The trocar is then placed 
through the incision. The trocar is rotated back and forth with a firm downward force 
until reaching the peritoneal cavity. Some studies suggest lifting the abdominal wall with 
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towel clips while advancing the trocar to reduce tenting and to increase control [46]–[49]. 
The shape of most blunt trocar tips is either long and conical, rounded, or dolphin-nose 
shaped (Figure 5). Since the advent of the optical trocar in the 1990s, it has become 
uncommon to place a blunt trocar as the primary access device [6], [44]. 
 
Figure 5: Image of several ENDOPATH XCEL blunt trocars (Ethicon, Somerville, NJ) [50]. 
1.4.2 Bladed (shielded) trocar 
The bladed trocar was first introduced in 1984 to decrease the force required to 
place a trocar and to eliminate the complications associated with Veress needle placement 
[44]. Bladed trocars have a spring-loaded safety shield that is retracted by the resistance 
of the abdominal wall (Figure 6). As the trocar advances through the abdominal wall, the 
blade is revealed, and the tissue is cut. As soon as the parietal peritoneum is breached, the 
safety shield is sprung back into its resting position to protect the blade, resulting in an 
audible pop. There is a time, however, where the blade is exposed in the peritoneal cavity 
and the safety shield has yet to protect the blade. Because of this, visceral injuries can be 
more common with bladed trocar placement compared to blunt or optical trocar 
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placement [51]. In 1996, the US Food and Drug Administration directed all trocar 
manufacturers to remove the term “safety” from packaging labels as there was no 
evidence that showed shielded trocars prevent injury more than other methods [5]. There 
are three different shapes of blades for shielded trocars: pyramidal, conical, and linear 
(Figure 7). The placement force of a bladed trocar has been shown to decrease the 
insertion force by at least one half (depending on the blade shape) compared to blunt 
trocar placement [52]. 
 




Figure 7: Diagram of the various tip types for peritoneal cavity access. [54] 
1.4.3 Optical trocar 
The optical trocar was developed as an enhancement to blind direct trocar 
placement. The first optical trocar was described by Dr. Steven Kaali in 1993 [55]. His 
device consisted of a conventional blunt trocar, a transparent cutting tip, and a pistol-grip 
handle. A laparoscope was inserted through the center of the trocar to enable visual 
feedback. Although Dr. Kaali’s presented article on the device established 
pneumoperitoneum before entry [55], optical trocar placement is now commonly done for 
primary entry.  
To place an optical trocar, a skin incision is made, and the trocar is placed into the 
subcutaneous area. As the trocar is inserted through the abdominal wall, the layers of the 
abdominal wall being dissected by the trocar can be visualized (yellow fat, white fascia, 
red muscle, and transparent peritoneum) [56]. As soon as the trocar breaks through the 
peritoneum, correct placement is confirmed by visualization of the abdominal organs, 
omentum, or mesentery. Even with this substantial increase in trocar function, the optical 
trocar system is not perfect as identifying the abdominal wall layers is not trivial and 
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injuries occur [57]. In a study with 164 optical trocar placements, only 62 times did the 
surgeon perceive the moment of peritoneal perforation [58]. From medical device-
reporting databases from 1994-2002, 79 serious complications were identified with 
optical-access trocars, including 37 major vascular injuries, 18 bowel perforations, and 20 
cases of severe bleeding from other sites including 3 liver lacerations and one stomach 
perforation. Four of the 79 complications resulted in deaths [59]. Although 79 serious 
complications occurred, this is, at least in part, due to the widespread use. No information 
on the percentage of complications is given. On the positive side, the optical trocar has 
been shown to decrease the time to placement [60]. It has also has been shown to give 
similar results and rates of failure whether being performed by a novice or an experienced 
surgeon [61]. 
Although there are many manufacturers of optical trocars, there are three general 
types: conventional optical trocars, the Visiport Plus, and the EndoTIP. Conventional 
optical trocars can have a pistol grip or a rounded handle. The tips of these trocars are 
transparent with either a blunt conical tip with plastic tissue separators or with a thin, 
laterally separating blade [5]. Thus, the tips either separate or lacerate the tissue. The tip 
is advanced by applying a moderate downward force and slowly rotating the trocar back 
and forth. The Kii Fios Optical Entry (Applied Medical, Rancho Santa Margarita, CA) is 
considered a conventional optical trocar and it includes a small insufflating port next to 
the tip for quick insufflation and an inflatable balloon on the distal end for trocar 




Figure 8: The Kii Fios Optical Entry trocar [62] 
The Visiport Plus optical trocar (Covidien, Norwalk, CT) contains a pistol-grip 
obturator and an 11mm or 12mm diameter cannula (Figure 9). It has a transparent dome-
shaped tip with a crescent-shaped knife blade enclosed. On the obturator is a trigger that, 
when activated, quickly fires and retracts the knife blade out 1mm. To the unaided eye, 
the movement of the blade is so fast as to be unnoticed [6]. Since the use of the blade is 
optional with the trigger, the trocar can be advanced through the abdominal wall by 
bladed laceration or by blunt force with the rounded tip. One study suggested that a 
combination of posterior pressure, trigger pulling, and gently twisting the trocar most 
effectively and safely advanced the trocar [56]. The Visiport, however, is not 
recommended for primary access in thin patients. When the aortic pulse is palpable 
during a relaxed abdominal examination, the patient may be considered too thin and an 




Figure 9: The Visiport Plus optical trocar [63] 
The Endoscopic Threaded Imaging Port (EndoTIP) (Karl Storz, Tuttlingen, 
Germany) is an optical cannula that can be used for primary access or after 
pneumoperitoneum has been established [64]. The EndoTIP and its associated method of 
use were first introduced by Dr. Artin Ternamian in 1997 [65]. The cannula is a reusable 
stainless steel device with a distal cannula segment and a proximal valve segment [65]. 
The cannula segment contains a single thread winding that ends with a blunt tip (Figure 
10) and is available in several different lengths and diameters for different surgical 
applications. Unlike optical trocars, the EndoTIP has no crystal tip distorting and 
compressing monitor images [44]. Thus, the layers of the abdominal wall are more 
identifiable compared to standard optical trocars. Since the trocar is threaded, the trocar is 




Figure 10: The Karl Storz EndoTIP Threaded trocar. Figure adopted without alteration from [6]. 
One study tested the efficacy of placing the EndoTIP without capnoperitoneum 
(CO2 pneumoperitoneum) [66]. The study was conducted from 2001-2005 and included 
165 patients. The cannula was successfully placed in all 165 patients without 
complications and with a mean placement time of <1 min. The researchers concluded that 
primary access with the EndoTIP is safe, effective, time-efficient, and a reliable method 
for peritoneal cavity access in laparoscopic surgery.  
Of the three access methods (closed, open, and direct) and the variety of devices 
available, no evidence has shown one method or device to be clinically superior to 
another. The method and device of choice generally depend on the surgeon’s competence 
and preference. 
1.5 Initial access locations 
Access to the peritoneal cavity can be achieved through several different 
locations. The location of choice depends on a variety of factors including weight, 
previous laparoscopic surgeries, and presence of abdominal adhesions. Because the 
design of the peritoneal cavity access device was intended for males and females, female-
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specific access locations (e.g., the posterior vaginal fornix and the fundus of the uterus) 
were excluded. 
1.5.1 Umbilicus 
The umbilicus is generally the first option for initial access as this is where the 
abdominal wall is the thinnest which results in an increased chance of successful 
placement, increased ease of entry, and a decreased recovery time (Figure 12) [67], [68]. 
On the other hand, the umbilicus tends to have a high rate (up to 21%) of infraumbilical 
adhesions following previous laparoscopic operations [69]. So, one deterrent to the use of 
the umbilical site for abdominal entry is a prior surgical procedure through this site. The 
presence of adhesions (scar tissue) at a prior surgical incision would increase the risk for 
entry injury during insertion of a needle or cannula at such a site. 
One major consideration when accessing the peritoneal cavity via the umbilicus is 
the location of the aortic bifurcation. Anatomic studies have shown that the bifurcation 
lies directly beneath the umbilicus in thin and ideal weight patients [70]. Thus, for these 
patients, the Veress needle or primary trocar should be inserted at a 45° angle relative to 
the abdominal wall, directed towards the pelvic hollow to prevent major vascular injury. 
The studies also show that with increasing body mass index (BMI), the umbilicus shifts 
caudally [70]. Thus, with increasing BMI, the insertion angle should be adjusted up to 
90° for obese patients.  
 Many surgeons prefer lifting the abdominal wall when accessing the peritoneal 
cavity via the umbilicus for stability and to increase the distance between the parietal 
peritoneum and the underlying viscera [9], [71]. However, this has been shown to have a 
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slightly increased injury rate and a decreased successful placement rate [9], [31]. One 
randomized study showed that manual elevation of the abdominal wall resulted in a 
higher rate of access failure [71]. Another study evaluated the effects of towel clips 
positioned on the linea alba and used to raise the abdominal wall [72]. They found the 
potential space between the parietal peritoneum and the abdominal viscera increased to 
11.8 mm when using this technique [72].  
In 2009, a novel abdominal wall suction device was presented to control 
abdominal wall lifting [73]. Known as LapCap 2 (Life Care Devices, Brighton, United 
Kingdom), the device is a dome-shaped suction tool designed to consistently lift the 
abdominal wall to separate the abdominal wall from the underlying viscera (Figure 11) 
[74]. A prospective cohort pilot study concluded that the device can significantly increase 
the distance between the linea alba and the intestines, vena cava, and the abdominal aorta 
[74].  
 
Figure 11: The LapCap2 abdominal wall suction device [75] 
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1.5.2 Left upper quadrant (Palmer’s point) 
Access via the left upper quadrant was first advocated by Raoul Palmer in 1974 
[76]. He proposed the use of “Palmer’s point” in patients who have had previous 
laparoscopic procedures at the umbilicus, patients with suspected umbilical adhesions, or 
patients with a large uterus. He also recommended Palmer’s point after three failed 
attempts at the umbilicus or in extremely obese or thin patients [76]. Regardless of these 
indicators, some surgeons have advised the use of Palmer’s point over the umbilicus for 
routine use [77]. Contraindications for using Palmer’s point include ascites, 
splenomegaly, hepatomegaly, suspected upper abdominal adhesions, a large abdominal 
mass that could be punctured, or gastric drainage failure [78]. Palmer’s point is located 3 
cm below the left subcostal margin on the midclavicular line (Figure 12) [31]. The 
pneumoperitoneum needle or primary trocar should be angled slightly off 90° relative to 
the abdomen, angled towards the midline but not so great an angle as to put the great 
vessels in the needle’s path [9].  
1.5.3 Mid upper abdomen (Lee-Huang point) 
The use of the Lee-Huang point was presented in 2001 by Lee et al. as another 
alternate location for primary access [79]. The access point is located midway between 
the umbilicus and the xiphoid process on the abdominal midline or 10 cm below the 
xiphoid process (Figure 12) [79]. The Lee-Huang point is recommended in patients with 
similar indicators as to when using Palmer’s point. Advantages of the Lee-Huang point 
include a thin abdominal wall, a central operative port, and it avoids abdominal adhesions 
from lower abdominal surgeries. The contraindication for using the Lee-Huang point is a 
patient who has had an operation in the supraumbilical region [31], [79]. 
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1.5.4 Left lateral port (Jain point) 
 In 2016, the Jain point was proposed as an alternate location when the first three 
options (umbilicus, Palmer’s point, and Lee-Huang point) are not viable [80]. The Jain 
point is located directly lateral to the umbilicus and 2.5 cm medial to a vertical line drawn 
from the left anterior superior iliac spine (Figure 12) [81]. Advantages of the Jain point 
are that it avoids intra-abdominal adhesions from previous surgeries at other locations, 
and there are no superficial or deep retroperitoneal major vessels in the needle/trocar’s 
path. In the study where the use of this point is first described, primary peritoneal cavity 
access through the Jain point was performed successfully in all 624 patients, all of which 
had previous abdominal surgeries. Among those patients, they found that 78.0% had 
intra-abdominal adhesions and 64.7% had umbilical adhesions [80].  
1.5.5 Ninth or tenth intercostal space 
Another alternate access point when umbilical entry contraindications are 
presumed is the left ninth or tenth intercostal space (Figure 12), as described by Reich et 
al. in 1995 [82]. To establish pneumoperitoneum, the Veress needle is placed through the 
ninth or tenth intercostal space at the anterior axillary line along the superior surface of 
the lowest rib attached to the sternum [44], [83]. Placing a Veress needle at this point is 
simplified as the parietal peritoneum adheres to the undersurface of the ribs in the costal 
margin [44]. After pneumoperitoneum is established, the primary trocar is generally 
placed at Palmer’s point [83]. A retrospective study of 918 procedures had only two 
instances of Veress needle entry complications: one perforated stomach and one entry 





Figure 12: Illustration of the primary access locations. The umbilicus (U) is generally used as the primary 
access port unless there are certain contraindications. Palmer’s point (P) is located 3 cm below the left 
subcostal margin on the midclavicular line. The Lee-Huang point (LH) is located midway between the 
umbilicus and the xiphoid process on the abdominal midline or 10 cm below the xiphoid process. The Jain 
point (J) is located directly lateral to the umbilicus and 2.5 cm medial to a vertical line drawn from the left 
anterior superior iliac spine. The final point (IS) is in the left ninth or tenth intercostal space. 
1.6 Possible injuries during initial peritoneal cavity access 
Complications secondary to the placement of the primary access device can be 
separated into two categories: major and minor. Major complications include injury to the 
aorta, vena cava, and the iliac vessels. Minor complications include injury to any hollow 
viscera (e.g., bowel and stomach), extraperitoneal insufflation, omental/mesentery 
insufflation, and failed entry.   
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Table 1 lists several studies evaluating the efficacy of the three different peritoneal 
access techniques along with the access device used if listed. Overall, the open technique 
had the lowest rate of major vascular injury and the closed technique had the lowest rate 
of minor complications. However, the complication rates of all three methods are 
comparable.  
1.6.1 Major Complications  
 Major vascular injury is the leading cause of mortality in laparoscopy with a 
reported mortality rate of 15% [3]. Major complications are rare, and most complications 
are quickly detected [6]. The risk of major vascular injury is increased in thin patients as 
the distance between the anterior abdominal wall and the major retroperitoneal vessels 
may be as little as two centimeters [3]. Although a major complication can theoretically 
occur when placing the needle/trocar at any of the primary access locations, they 
typically occur when the umbilicus is used [3]. When comparing non-significant results 
from a meta-analysis, direct trocar entry and the open trocar entry method showed fewer 
major complications than Veress needle placement [19].  
1.6.2 Minor Complications  
Even though minor complications are deemed “minor”, they can still be 
potentially life-threatening. Some studies have revealed that 30-50% of bowel injures and 
15-50% of vascular injuries go undiagnosed at the time of surgery [2]. This can lead to a 
high mortality rate (2.5-5%) with bowel injury ranking third among the causes of death 
from laparoscopic surgeries behind major vascular injury and anesthesia [44], [85]. On 
the other hand, some minor complications such as extraperitoneal insufflation and 
omental emphysema, are so minor that they may not be reported as often as they occur 
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[6]. A meta-analysis comparing the three entry techniques concluded the order of minor 




Table 1: A comprehensive review of several studies evaluating the major and minor rates of injury 
associated with each peritoneal cavity access technique. Overall, the three techniques have very 
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Chapter 2 – Military Battlefield Conditions 
 
Battlefield conditions vary substantially from surgical rooms. Devices that are 
intended for use on the battlefield must adhere to a different set of standards and have 
different requirements. They must function in a variety of environments, temperatures, 
and terrains. They also need to be easy to use and require little to no additional training as 
the person operating them is a military field medic rather than a trained surgeon. 
2.2 Battlefield medical treatment 
Before an injury, field medics are just like everyone else on a team in that they 
carry combat equipment, and they are expected to engage in warfare. After an injury, 
however, the field medic’s main job is to administer basic medical care (tactical combat 
casualty care) and to get the injured soldier to safety as quickly as possible. There are 
three levels of tactical combat casualty care (TCCC): care under fire, tactical field care, 
and tactical evaluation care [111].   
2.2.1 Care under fire 
Care under fire is the first stage when the medic is expected to aid the injured 
soldier while under hostile fire. The risk of further injury to either the fallen soldier or the 
medic is high. Because of this, the priorities are (1) to suppress the enemy by returning 
fire or by other means, (2) transport the casualty to cover to prevent further injury, and 
(3) treat immediately life-threatening hemorrhaging. Medical supplies at this point are 
limited to the materials in the field medic’s bag [111]. 
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2.2.2 Tactical field care 
Tactical field care is the stage immediately following care under fire or that 
occurs if an injury did not occur during hostile fire. The risk of further injury has 
decreased significantly but medical supplies are still limited. Medical treatment can vary 
depending on the tactical situation and time to evacuation (which can vary between 
minutes and hours). The priority in this phase is to complete a trauma assessment and to 
treat major injuries not addressed in the first phase. Other issues addressed are clean 
airways, shock, hypothermia, pain, and infection [111].  
2.2.3 Tactical evaluation care 
 In the tactical evaluation care stage (the final stage of care that the field medic is 
trained to administer), the injured soldier is picked up and transported to a medical care 
facility. The transportation vehicles are typically Humvees or Black Hawk helicopters. 
The risk of further injury has decreased substantially. The availability of additional 
medical personnel and medical supplies are dependent on what is available in the 
transportation vehicle. The priority at this stage is to reassess and continue care 
administered during the previous two stages. Additional care may be administered 
depending on the increased capabilities of the transportation vehicle (e.g., increased 
airway management and oxygen administration) [111]. Administration of OMBs would 
likely occur at or following this stage. If a fallen soldier is unable to breathe, OMB 
administration could be lifesaving. 
2.3 Field medic training 
Field medics receive substantially less medical training than general surgeons. 
Whereas a general surgeon typically receives five years of surgical training, a field medic 
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receives only 16 weeks of medical training. During a field medic’s training, they gain 
knowledge in medical terminology, anatomy, physiology, standard nursing practices, 
emergency medical treatment (particularly cardiopulmonary resuscitation), aseptic 
techniques, administration of some prescribed drugs and immunizations, population 
health concepts, methods for transporting sick or wounded soldiers, hygiene, sanitation, 
fundamentals of primary care management, usage and maintenance of neurodiagnostic 
equipment, and emergency medical and dental treatment [112].  
2.4 The field medic’s bag 
Depending on the mission, a field medic’s equipment bag can vary. Because the 
field medic is expected to carry combat and medical equipment, weight and size are 
crucial. Typical medical supplies in the bag include gauze, syringes, scalpels, chest tubes, 
pain medications, and bandages. Fully packed, most bags weigh between 25 and 30 lbs., 
but some bags weigh up to 50 lbs.  
2.5 Typical soldier profile 
 Because of the physical requirements the armed forces maintain, the soldier 
profile can be somewhat generalized. Both male and female soldiers experience combat, 
but the majority of wounded and killed soldiers are male [113]. Each of the armed forces 
maintains physical fitness requirements (e.g., complete so many push-up or sit-ups in two 





Table 2 lists the maximum allowable body fat percentage by age and gender for each of 
the armed forces, which is generally evaluated every six months [114]–[118].  
 
Table 2: List of the maximum allowable body fat percentage for each of the armed forces by age and 
gender [114]–[118]. 
Age 
Air Force Marines Army Navy Coast Guard 
Male  Female Male  Female Male  Female Male  Female Male  Female 
17 20% 28% 18% 26% 20% 30% 22% 33% 22% 32% 
18 20% 28% 18% 26% 20% 30% 22% 33% 22% 32% 
19 20% 28% 18% 26% 20% 30% 22% 33% 22% 32% 
20 20% 28% 18% 26% 20% 30% 22% 33% 22% 32% 
21 20% 28% 18% 26% 22% 32% 22% 33% 22% 32% 
22 20% 28% 18% 26% 22% 32% 23% 34% 22% 32% 
23 20% 28% 18% 26% 22% 32% 23% 34% 22% 32% 
24 20% 28% 18% 26% 22% 32% 23% 34% 22% 32% 
25 20% 28% 18% 26% 22% 32% 23% 34% 22% 32% 
26 20% 28% 19% 27% 22% 32% 23% 34% 22% 32% 
27 20% 28% 19% 27% 22% 32% 23% 34% 22% 32% 
28 20% 28% 19% 27% 24% 34% 23% 34% 22% 32% 
29 20% 28% 19% 27% 24% 34% 23% 34% 22% 32% 
30 24% 32% 19% 27% 24% 34% 24% 35% 24% 34% 
31 24% 32% 19% 27% 24% 34% 24% 35% 24% 34% 
32 24% 32% 19% 27% 24% 34% 24% 35% 24% 34% 
33 24% 32% 19% 27% 24% 34% 24% 35% 24% 34% 
34 24% 32% 19% 27% 24% 34% 24% 35% 24% 34% 
35 24% 32% 19% 27% 24% 34% 24% 35% 24% 34% 
36 24% 32% 20% 28% 24% 34% 24% 35% 24% 34% 
37 24% 32% 20% 28% 24% 34% 24% 35% 24% 34% 
38 24% 32% 20% 28% 24% 34% 24% 35% 24% 34% 
39 24% 32% 20% 28% 24% 34% 24% 35% 24% 34% 




Chapter 3 – Preperitoneal insufflation vs initial peritoneal cavity 
insufflation 
 
While many devices can access the peritoneal cavity relatively safely (see Chapter 
1), none of them are suited or intended for use outside the surgical room, let alone the 
battlefield. A study was performed where concomitant insufflation was found to have a 
higher rate of successful entry with little to no issues with preperitoneal insufflation [26]. 
Several other studies have shown pressure profiling to be the most reliable test of 
successful placement [119], [120]. We theorized that by combining concomitant 
insufflation and pressure profiling we could determine when the peritoneal cavity had 
been beached. In other words, by applying a certain pressure while advancing through the 
abdominal wall, we could detect the moment the peritoneal cavity was entered by a 
pressure drop. The following study was published in Surgical Endoscopy and was 
performed to determine the optimal pressure that would not cause preperitoneal 
insufflation (and give a false positive) but would initially insufflate the peritoneal cavity 
(indicating successful placement) [121]. Special acknowledgment is given to the 
coauthors of the article – Benjamin Wankum, Sean Crimmins, Mark Carlson, and 
Benjamin Terry – who helped conceive, perform, and document the study.  
3.1 Introduction 
Laparoscopic surgery is a minimally invasive technique that utilizes percutaneous 
access to the peritoneal space, which under physiological conditions is only a potential 
space [122]. Although the standard techniques to access the peritoneal space are 
relatively safe, most adverse events associated with this access occur during initial entry 
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[44], [94], [122]. These events include visceral perforation [123], preperitoneal 
(abdominal wall) insufflation [124], gas embolism [125], abdominal hematoma [126], 
and failure to gain peritoneal access [6]. Research and development of technologies to 
increase the safety and efficacy of peritoneal access during laparoscopic surgery have 
been ongoing for decades, but incidents of injury have remained constant over the past 25 
years [127]. 
There are various techniques for accessing the peritoneal cavity but the closed 
entry method is one of the more common methods [44]. One variation of the closed 
method involves the Veress insufflation needle where a small (several millimeters) skin 
incision is made through which the needle is inserted into the peritoneal cavity [128]. 
Safety checks to confirm the placement of the needle within the peritoneal cavity include 
Palmer’s test, the pressure profile test, the double click acoustic test, and the hanging 
saline drop test [5], [29], [30]. The pressure profile test is the most sensitive and reliable, 
but all of these safety checks have drawbacks in confirming successful entry [5], [29], 
[30]. 
After peritoneal access has been obtained, carbon dioxide gas flow through the 
needle is initiated and the peritoneal cavity is insufflated (this technique is known as 
subsequent insufflation) [26]. Gas insufflation of the peritoneal cavity creates a working 
space in which an operation can be performed [129]. Alternatively, concomitant 
insufflation can be performed, in which the insufflation needle is inserted through the 
skin incision and into the peritoneal cavity while carbon dioxide flows through the needle 
[26]. If concomitant insufflation is paired with the pressure profile test, then a pressure 
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drop indicates the Veress needle has breached the parietal peritoneum and has accessed 
the potential space of the peritoneal cavity [27]. A drawback to both subsequent and 
concomitant insufflation is preperitoneal insufflation, which can cause subcutaneous 
emphysema and access failure [28].  
 Several different studies have found that the pressure to create peritoneal cavity 
initial insufflation is less than 10 mmHg [29], [30], [44], but the insufflation pressure of 
the abdominal wall has yet to be determined. The goal of this study was to find an 
optimal range (𝑃𝑜𝑝𝑡) of static pressures which would be low enough to facilitate 
placement of a Veress needle into the peritoneal space without causing preperitoneal 
insufflation (𝑃𝑝𝑝𝑖) (Figure 13), yet high enough to separate abdominal viscera (such as 
the small intestine) from the parietal peritoneum (𝑃𝑝𝑐) as described by the inequality: 
𝑃𝑝𝑐 < 𝑃𝑜𝑝𝑡 < 𝑃𝑝𝑝𝑖 
where 𝑃𝑝𝑐 is the initial pressure to insufflate the peritoneal cavity, 𝑃𝑜𝑝𝑡 is the optimal 
pressure range, and 𝑃𝑝𝑝𝑖 is the preperitoneal insufflation pressure. 
 By knowing the minimum pressure required to separate the layers of the 
abdominal wall, one should be able to minimize the risk of preperitoneal insufflation 
while obtaining safe and efficient entry into the peritoneal cavity. To find the minimum 
preperitoneal insufflation pressure, a Veress needle was inserted into a porcine abdomen 






Figure 13: Visualization of preperitoneal insufflation within the rectus abdominis muscle (a) and initial 
separation of the abdominal organs from the parietal peritoneum (b). Layers of the abdominal wall 
depicted are 1. Skin, 2. Subcutaneous fat, 3. Anterior rectus sheath, 4. Rectus abdominis muscle, 5. 
Posterior rectus sheath, 6. Preperitoneal fat, 7. Parietal peritoneum, and 8. Abdominal viscera. 
3.2 Methods 
The experiments reported herein were conducted according to the principles set 
forth in the National Institutes of Health Publication No. 80-23, Guide for the Care and 
Use of Laboratory Animals and the Animal Welfare Act of 1966, as amended [130]. The 
animal protocol pertaining to this manuscript was approved by the Institutional Animal 
Care and Use Committee (IACUC) at the University of Nebraska-Lincoln (ID #1909). 
All procedures were performed in animal facilities approved by the Association for 
Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and 
by the Office of Laboratory Animal Welfare of the Public Health Service [131], [132]. 
The Duroc and Duroc-Landrace cross pigs that were used for the study were purchased 
from the Plymouth Ag Group, Beatrice, NE [133].  
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A power analysis with an estimated difference in means of 10 mmHg and a power 
of 0.8 was used to determine that five animals were necessary for the study. Although 
only five pigs were needed, twelve pigs were available from other animal studies. Thus, 
the study was performed on 12 female pigs (two Duroc and ten Duroc-Landrace cross). 
The two Duroc and three of the Duroc-Landrace cross-bred pigs’ weights ranged from 
45-50 kg (47.2 ± 2.05), while the remaining seven Duroc-Landrace cross bred weights 
ranged from 72-76 kg (74.2 ± 1.46). Pigs were selected to model the human abdominal 
wall because of their dual-layer fascia, analogous underlying anatomy, and similar tissue 
mechanical properties [134]. The experiments were completed on non-living subjects, 
within two hours of euthanasia.  
The animals were administered lipopolysaccharides (LPS) via the trachea and 
developed acute respiratory distress syndrome (ARDS) as part of two other studies 
(IACUC ID #1624, #1944). After euthanasia and before this study, the pig’s heart and 
lungs were removed for necropsy purposes. To remove the heart and lungs, the front legs 
were splayed by cutting the subscapularis, teres major, and latissimus dorsi muscles to 
stabilize the carcass. Then the superficial and deep pectorals, sternocephalicus, serratus 
ventralis, and sternothyroideus were severed to access the sternebra. Starting cranially 
and working caudally, each sternebra was separated from the rib by cutting the costal 
cartilage. The cartilage between the first left and right rib was then cut. To further expose 
the thoracic cavity the ribs were manually broken. Using blunt dissection, the cranial 
vena cava, esophagus, and trachea were then exposed and severed at the thoracic inlet. 
The heart and lungs were then pulled up and out of the thoracic cavity. This then exposed 
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the caudal vena cava and esophagus next to the diaphragm which were severed. The 
thoracic organ block, in its entirety, was then removed from the carcass. Throughout the 
heart and lung removal, special care was taken to not puncture or cut into the peritoneal 
cavity. Thus, it was anticipated the removal did not affect the integrity of the abdominal 
tissue and organs. 
The experimental setup is shown in Figure 14. An air tank was used to provide 
pressure for the tests. The initial air pressure was controlled with a pressure regulator 
attached to the air tank and was set to around 100 psi. An insufflator (Laparoflator 26012, 
Karl Storz, Germany) and a pressure regulator (1888K1, McMaster-Carr, USA) with a 
calibrated pressure gauge attached (4269K1, McMaster-Carr, USA) were connected in 
parallel to the air supply. The insufflator was connected to a disposable Veress needle 
(PN150, Ethicon Endo-Surgery, Guaynabo, Puerto Rico) and was used to control 
pneumoperitoneum. A second Veress needle connected to the pressure regulator was used 
to control the concomitant insufflation pressure. After making 5 mm skin incisions [44], 
all needles were inserted slowly and incrementally at a 90° angle relative to the abdomen 




Figure 14: Experimental setup for determining the optimal initial insufflation pressure range. The Veress 
needle attached to the insufflator was used to maintain pneumoperitoneum at 10 mmHg while the other 
Veress needle was used for preperitoneal insufflation testing.  
Five needle placement categories resembling anatomical locations were identified 
for peritoneal cavity access (Figure 15, Table 3). The X category had one test location, 
just below the umbilicus, and is a common entry location during a laparoscopic procedure 
[135]. The M category was along the abdominal midline. The Veress needle is frequently 
placed by physicians beneath the umbilicus or sometimes at the Lee-Huang point [31]. 
The Lee-Huang point is located midway between the xiphoid process and the umbilicus 
along the midline [31]. It typically is used when previous operations preclude the sub-
umbilical incision or after failed access attempts below the umbilicus [136]. The 
remaining three placement categories (P, C, and B) assumed the abdominal wall was 
relatively symmetrical about the abdominal midline. The P category was located near 
Palmer’s point which is 3 cm below the left subcostal border in the midclavicular line 
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[31]. It may be used as another alternative to the sub-umbilical placement for patients 
who are known or suspected to have periumbilical adhesions or have failed attempts at 
the umbilicus [137]. It also may be considered for both obese and very thin patients [44]. 
The C and B categories are not typically used for initial access in laparoscopic operations 
but can be used for subsequent trocar insertion [135], [138]. 
 
Figure 15: Needle locations for the five placement categories X, M, P, C, and B 
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Table 3: Needle placement category locations and their respective representation of common peritoneal 
cavity access points. The X category placement tested the initial insufflation pressure. All other categories 
tested the preperitoneal insufflation pressure. 
Category Anatomical Location Category Representation 
# of Needle 
Placements 
X Sub-umbilicus Sub-umbilicus 1 
M Median Plane Sub-umbilicus, Lee-Huang 8 
P Right and left upper quadrants Palmer's Point 8 
C Transumbilical plane Subsequent trocar placement 8 
B Right and left lower quadrants Subsequent trocar placement 8 
     Total 33 
 
The first needle was placed at location 1X, and insertion into the peritoneal cavity 
was indicated by the double click test [31]. After the needle was placed, the static 
pressure was increased at intervals of 2.6 mmHg (based on the resolution of the pressure 
gauge) starting at 0 mmHg. Once airflow occurred, indicating separation of the visceral 
and parietal peritonea, the pressure was recorded as the initial insufflation pressure. This 
could only be tested once per animal because, according to pilot studies, the pressure to 
subsequently insufflate the peritoneal cavity decreased after the initial separation of the 
viscera from the abdominal wall. Pneumoperitoneum was then established with an 
insufflator and maintained at a cavity pressure of 10 mmHg. While the only initial 
indication of correct needle placement was the double click test, it was confirmed when 
insufflation occurred, and pneumoperitoneum was established.  
The initial Veress needle at 1X remained inside the peritoneal cavity for the 
remainder of the experiment to maintain pneumoperitoneum. A second Veress needle 
was inserted with concomitant air insufflation to determine the separation pressure of the 
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abdominal wall. Pneumoperitoneum was sustained for the remaining needle tests because 
the lack of resistance on the entering needle (from the separated abdominal wall and 
underlying viscera) indicated to the user when the needle tip had breached the parietal 
peritoneum. The second needle was inserted at several different locations. One site from 
each of the remaining test categories (M, B, P, C) was randomly selected for each 
pressure beginning at 5.2 mmHg and ranging up to 41.4 mmHg at intervals of 5.2 mmHg. 
The needle was placed slowly and incrementally. At each increment, the downward force 
on the Veress needle was momentarily released to allow airflow detection. Airflow was 
confirmed by the pressure drop that occurred as the pressure changed from static to 
dynamic pressure. If insufflation occurred before breaching the peritoneum, the test site 
and pressure were recorded as a failure to access the peritoneal cavity. If the needle made 
it into the peritoneal cavity without causing preperitoneal insufflation, then the test site 
and pressure were recorded as a success. 
3.3 Results 
Figure 16 shows the distribution of the preperitoneal insufflation occurrences for 
the M, P, C, and B categories at each pressure interval. As seen in the figure, category M 
had two instances with uncharacteristically lower insufflation pressures of 15.5 and 20.7 
mmHg on two different pigs. These tests were both performed at location 8M (Figure 15) 
which may be too low on the abdominal wall. Thus, the assumption that the linea alba has 
consistent anatomy from 1M to 8M may be invalid on some pigs. That said, the 
difference in the number of preperitoneal insufflations between the left and right sides 
was statistically insignificant (p > 0.05), indicating that the assumption of anatomical 




Figure 16: As the insufflation pressure increases, the likelihood of preperitoneal insufflation also 
increases. The histogram depicts the number of instances where preperitoneal insufflation occurred in each 
test category and at each insufflation pressure. All test categories had preperitoneal insufflation pressures 
at or above 20.7 mmHg, except category M which had two irregularities at 15.5 and 20.7 mmHg.  
The lowest pressures to insufflate the abdominal wall per category per pig 
(excluding the anomalies in the M category) were taken to compare to the peritoneal 
cavity initial insufflation pressure (category X) (Figure 17). During the study, some 
carcasses did not have a preperitoneal insufflation between 5.2 and 41.4 mmHg for 
certain test categories. For these categories, pressure tests continued at intervals of 5.2 
mmHg until the first instance of preperitoneal insufflation occurred. The locations for the 
additional tests were cranial to the most superior test category location. One-way 
ANOVA was used to compare the mean confidence intervals for the test categories, 
which showed there was a significant difference between mean initial peritoneal cavity 
insufflation pressure and each of the means of the lowest preperitoneal insufflation 
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pressures (p < .05). Also, for our sample size, there was no statistical difference in the 
minimum insufflation pressure between the two weight groups (~50 kg and ~75 kg) (p 
>.05). Category X had an initial insufflation pressure of PX = 8.83 ± 4.19 mmHg (mean ± 
SD). The average lowest preperitoneal insufflation pressures for categories M, P, C, and 
B were PM = 40.08 ± 7.68 mmHg, PP = 31.89 ± 6.91 mmHg, PC = 29.31 ± 5.55 mmHg, 
and PB = 28.87 ± 6.02 mmHg, respectively. 
 
Figure 17: There exists a pressure threshold that initially insufflates the peritoneal cavity and does not 
cause abdominal wall (preperitoneal) insufflation. The distribution of the lowest pressures to initially 
insufflate the peritoneal cavity (X) and the lowest pressures to cause preperitoneal insufflation at each test 
category (M, P, C, B) for each pig are shown. There was a statistically significant difference (p <.05) 
between the mean initial peritoneal cavity insufflation pressure (PX = 8.83 ± 4.19 mmHg) and each of the 
means of the lowest preperitoneal insufflation pressures (PM = 40.08 ± 7.68 mmHg, PP = 31.89 ± 6.91 




In this study, an acceptable range of insufflation pressures was determined at four 
different locations on the abdominal wall, as well as the initial peritoneal cavity 
insufflation pressure in human-sized porcine carcasses. Our results suggest Veress needle 
pressures greater than 20 mmHg at categories P, C, and B and 30 mmHg at category M 
are likely to cause preperitoneal insufflation. On the other hand, pressures of 8.83 ± 4.19 
mmHg (mean ± SD) will initially insufflate the peritoneal space. For both subsequent and 
concomitant insufflation, the target insufflation pressure should be set to a pressure lower 
than the determined 20 mmHg to avoid preperitoneal insufflation. To compare our 
porcine results to humans, Vilos, et al. determined the initial peritoneal cavity insufflation 
pressure in 256 female humans to be 4.09 ± 1.34 mmHg (mean ± SD) [27]. However, 
there have not been any studies to determine the minimum preperitoneal insufflation 
pressure within humans. An experiment on fresh cadavers modeled after this study could 
be used to find such values. 
To avoid instances of preperitoneal insufflation while using the technique of 
subsequent insufflation, the initial insufflation pressure should be within the optimal 
range (𝑃𝑜𝑝𝑡). This way the pressure is low enough that if the needle were incorrectly 
placed within the abdominal wall, it would not insufflate. After correct placement is 
confirmed by carbon dioxide flowing at the lower pressure, the insufflator setting can be 
increased to the desired pneumoperitoneum pressure. For concomitant insufflation, as the 
needle is passed through the abdominal wall layers, the initial insufflation pressure 
should be within the optimal range (𝑃𝑜𝑝𝑡). Correct placement can then be confirmed as 
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carbon dioxide flow begins after breaching the parietal peritoneum. After successfully 
locating the cavity, the insufflation pressure can be increased to the desired 
pneumoperitoneum pressure.  
During one carcass experiment, the initial Veress needle was over-inserted into 
the bowel without any indication. The initial insufflation pressure reading was 7.8 
mmHg. Thinking the needle was in the potential space of the peritoneal cavity, the 
experiment continued and the Veress needle was connected to the insufflator. However, 
once insufflation began, the cavity did not insufflate evenly as observed when the 
insufflating needle is placed correctly. This particular test was abandoned, and the carcass 
abdomen was cut open for inspection. After investigation, the needle had entered and 
insufflated the large intestine. This adverse event illustrates the need for more research on 
initial peritoneal cavity access. This study was designed to determine the pressure range 
suitable to avoid preperitoneal insufflation during Veress needle insertion; however, more 
research is needed to further address and mitigate the risk of visceral injury. 
While the Veress needle is the most common means for establishing 
pneumoperitoneum, some surgeons prefer the direct trocar method where the primary 
trocar is placed without pneumoperitoneum [31]. The results from this study can likely be 
applied to more devices than just the Veress needle by ensuring the initial insufflation 
pressure (or concomitant insufflation pressure) is within the optimal range (𝑃𝑜𝑝𝑡). 
However, further testing should be conducted to prove this hypothesis. 
A limitation of this study was that the initial peritoneal cavity insufflation 
pressure was only measured below the umbilicus. Although this is the most common 
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location for placement of the Veress needle [31], future work should be done to show that 
Palmer’s point and the Lee-Huang point also have lower initial insufflation pressures 
(𝑃𝑝𝑐) than their respective preperitoneal insufflation pressures (𝑃𝑝𝑝𝑖). Additionally, the 
study’s objective was whether a certain air pressure resulted in preperitoneal insufflation 
within any layer of the abdominal wall. It may also be useful to classify the pressure to 
insufflate each of the individual abdominal wall layers. In particular, it was observed that 
the lowest pressure to result in preperitoneal insufflation usually occurred directly 
superficial to the parietal peritoneum. Further testing should be done to characterize this 
section of the abdominal wall as it may be the most likely location for preperitoneal 
insufflation. Also, omental emphysema and visceral insufflation are issues, and further 
testing should be done to classify the insufflation pressure of the omentum, mesentery, 
and the various abdominal organs to determine if pressure profiling is also capable of 
detecting over-puncture of the Veress needle [119]. 
3.5 Conclusion 
 We determined, in human-sized porcine models, the initial peritoneal cavity 
insufflation pressure below the umbilicus and the preperitoneal insufflation pressure at 
four different anatomical categories. Veress needle pressures greater than 10 mmHg 
resulted in initial cavity insufflation (𝑃𝑝𝑐) and pressures greater than 20 mmHg resulted in 




Chapter 4 – An intraperitoneal catheter placement device 
 
A set of initial requirements for the intraperitoneal catheter placement device to 
fulfill the project objective were predetermined. The initial requirements were divided 
into two sets: user needs requirements and performance requirements. The user needs 
requirements encompassed the initial requirements related to who would be using the 
device and who the device was intended to be used on. The performance requirements 
encompassed the product design requirements. All initial requirements were as follows: 
1. User Needs Requirements 
1.1. The device must be able to be used by an Air Force Medical Technician with 
the knowledge and skills outlined in Section C 2.1.1.1 of AFSCs 4N0X1X 
[112]  
1.2. The device must be able to function on service personnel with less than 36% 
and 26% body fat for females and males, respectively (the maximum 
allowable fat percentage by gender for any military branch) 
2. Performance Requirements 
2.1. The device must place a catheter into the abdominal cavity 
2.2. The device must withstand a range of environmental extremes (temperature [0 
< T < 54 °C], relative humidity [0% < H < 100%], dust, etc.)  
2.3. The device must place the catheter in less than 2 minutes 
2.4. The device should enable the medical technician to assess any visceral 
perforations caused by the insertion of the catheter at least 90% of the time 
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2.5. The device must ensure a proper seal of the port-site to maintain intra-
abdominal pressures up to 15 mmHg 
2.6. The device must have an indicator of successful or unsuccessful placement 
2.7. The device must anchor/secure the catheter after placement 
2.8. The device must use only biocompatible materials for materials that come in 
contact with tissue 
2.9. The device should weigh no more than 1.0 kg  
2.10. The device should cost less than $100 
2.11. The device must be sterile as dictated by ISO 10555-1:2013 [139] 
2.12. When used by a surgeon, the device must have a failure rate lower than 
current cavity access methods (< 0.1% - 0.5%) 
2.13. When used by a field medic, the device must have a failure rate not to exceed  
that of a surgeon using current cavity access methods (≈ 0. 1% - 0.5%) 
After research and brainstorming, we conceived a catheter placement device that 
uses a threaded trocar and air pressure to safely access the peritoneal cavity. Based on the 
preperitoneal insufflation pressure study (Chapter 3), we determined the optimal pressure 
for initially insufflating the peritoneal cavity to be 20 mmHg. This pressure, theoretically, 
always initially insufflates the abdominal cavity and never insufflates the abdominal wall. 
Thus, as a trocar is inserted through the abdominal wall with 20 mmHg applied, no flow 
(and no extraperitoneal insufflation) will occur as the abdominal wall tissue plugs the end 
of the trocar. As soon as the parietal peritoneum is breached, the pressure is sufficient to 
initially insufflate the peritoneal cavity and flow occurs. This method of accessing the 
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peritoneal cavity is very similar to using the pressure profile test when concomitantly 
insufflating.  
Palmer’s point was selected as the trocar insertion location for two reasons. First, 
at Palmer’s point, the posterior and anterior rectus sheaths are separated by the rectus 
abdominus muscle. When these two layers are combined at the linea alba, it is difficult 
for the blunt tip of a threaded trocar to penetrate. When they are separated, an incision 
past the anterior rectus sheath can be made relatively easily. The trocar can then be 
inserted into the incision and the tip of the trocar is able to penetrate past the posterior 
rectus sheath with no issues. Second, if an incision is made beneath the umbilicus and 
past the linea alba, there is only a layer of preperitoneal fat to provide a cushioned space 
for too deep of an incision. In thin patients (or fit military personnel), the preperitoneal 
fat layer can be extremely small. This could increase the chance of over-puncture into the 
peritoneal cavity. Thus, an incision at Palmer’s point with the additional muscle layer can 
be a safer and simpler incision.  
With the optimal insufflation pressure determined, we created a peritoneal cavity 
access prototype device. The device has three major components: a threaded trocar, a 





Figure 18:A prototype of the intraperitoneal catheter placement device. 
4.1 The threaded trocar 
The threaded trocar was modeled after the Ternamian EndoTIP (Figure 10). We 
chose a trocar with threads since the advancement through the abdominal wall and into 
the peritoneal cavity is far more controllable than with other trocars or needles. More 
importantly, advancement is dependent on the number of rotations rather than the 
downward penetrating force. This helps the trocar to be inserted in a variety of conditions 
and by minimally trained medical personnel. For example, inserting a trocar on a 
Blackhawk helicopter or a moving Humvee would be difficult as there would be random 
bumps and accelerations. With rotation controlling the trocar’s advancement, the 
possibility of accidentally plunging into the peritoneal cavity would be minimized.  
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The tip of the trocar is also blunt. It is sharp enough to separate the tissue with a 
large enough rotational force but dull enough that penetration requires some effort. This 
also helps mitigate iatrogenic injury. As mentioned in Chapter 1, there has only been one 
study evaluating the EndoTIP for initial peritoneal cavity access. During the study, the 
EndoTIP was successfully placed in all 165 patients without any complications [66]. 
4.2 The hand crank 
During initial testing of the EndoTIP, we found the rotation of the trocar to be 
unstable and awkward without a centering laparoscope. We added a hand crank to 
combat these issues. The hand crank is connected to the trocar by a set of miter gears. To 
advance the trocar, a moderate downward force is placed on the outside case with the 
non-dominant hand while the dominant hand rotates the hand crank.  
4.3 The pressure cylinder 
The EndoTIP was designed as an optical trocar (i.e., it was designed to have a 
laparoscope placed through the cannula during insertion) so the surgeon knows the 
instant when the parietal peritoneum is breached. Without a laparoscope, we needed some 
other means of letting the user know when to stop advancing the trocar. A flexible 
pressure cylinder with a dynamic plunger was used to notify the user. When the tip of the 
trocar is within the abdominal wall, no flow occurs, and the plunger stays still. As soon as 
the peritoneal cavity is reached, the pressure within the plunger is released and the 
plunger advances. This movement of the plunger indicates to the user that the cavity has 
successfully been reached.  
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The pressure cylinder is composed of a rubber bellows, a plastic plunger, and a 
spring (Figure 19). When the plunger is pulled back, the spring is compressed against the 
case. The port to the bellows can be closed and the plunger released to generate pressure 
within the bellows. The spring was selected with a length and spring constant such that 
the pressure within the bellows equaled 20 mmHg. A bellows was used as a flexible 
cylinder to eliminate the dynamic friction (e.g., O-ring friction) experienced with other 
dynamic pressure cylinders. This enabled the pressure cylinder to consistently reach the 
low pressure of 20 mmHg.  
 
 
Figure 19: Detailed cross-section view of the intraperitoneal catheter placement device 
4.4 Surgical procedure 
The first step to placing the trocar is to charge the pressure cylinder by pulling 
back on the bellows plunger and by pushing on the axle plunger. A 10 mm skin incision 
is then made at Palmer’s point past the anterior rectus sheath. After the trocar is inserted 
into the incision, the tip of the trocar must be sufficiently sealed against the tissue of the 
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abdominal wall before the axle plunger can be retracted to open the valve to the pressure 
cylinder. Some preliminary tests revealed that three rotations are sufficient to create a 
seal, but this should be further tested. After opening the valve, the trocar is advanced 
slowly by applying a moderate downward force and by rotating the hand crank. It should 
be noted that the added pressure from advancing the trocar can be great enough that the 
20 mmHg is not enough to insufflate the cavity when it is reached. As a safety measure, 
at every half turn, advancement should be paused, and the trocar should be gently pulled 
up on. If the cavity has been reached, this enables insufflation to occur and the movement 
of the bellows plunger to be detected. After the cavity is reached, the trocar can be 
disconnected from the rest of the placement assembly. The catheter can then be placed 
through the trocar and treatment can begin. The following is a summary of the steps to 
catheter placement: 
1. Ensure the axle plunger is in the open position (pulled back). 
2. Pull back on the bellows plunger to create the insufflating pressure. 
3. While still holding on to the retracted bellows plunger, close the axle plunger 
(push-in). 
4. Sterilize Palmer’s point with an alcohol or iodine swab. 
5. Make a 10 mm incision at Palmer’s point until the rectus abdominus muscle is 
visible (just past the anterior rectus sheath). 
6. Place the tip of the trocar just past the anterior rectus sheath in the incision. 
7. Advance the trocar 3 revolutions clockwise by rotating the hand crank and 
applying a moderate (<10 N) downward force. 
55 
 
8. While maintaining a downward force, pull back on the axle plunger to open the 
pressure valve. 
9. Continue inserting the trocar by rotating the hand crank. 
a. Pull back on the trocar placement system every ½ rotation to check if the 
tip has reached the peritoneal cavity. 
b. Stop rotations when the bellows plunger moves from the retracted state to 
the relaxed state. 
10. Detach the placement system from the trocar. 
11. Near the inserted trocar, lightly lift the abdominal wall.  
12. Slowly insert the catheter through the trocar and into the peritoneal cavity. 
13. Begin treatment. 
4.5 Limitations 
Preliminary tests of the catheter placement device functionality have been 
successful in pigs thus far (data not shown in this thesis). However, there are still several 
limitations to the current design. The first and most notable limitation is that the optimal 
pressure range for avoiding preperitoneal insufflation but causing initial peritoneal 
insufflation was found in pigs. Another study must be performed to determine the optimal 
pressure range in humans. Preferably, the human subjects would have similar body 
characteristics as those found in the United States military.  
Another limitation is the fact that the incision must go past the anterior rectus 
sheath and down to the muscle. This can be quite deep and introduces the possibility of 
iatrogenic injury to the abdominal organs if done improperly. An improvement might be 
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changing the trocar tip geometry so that it can easily penetrate tough tissue. Furthermore, 
if the tip can penetrate the linea alba, the primary incision could be beneath the umbilicus 
which would allow for a wider range of pressures to be used (Figure 17). Another option 
would be to create an incision device that creates a consistent incision and does not 
penetrate too far past the anterior rectus sheath. Thus, the chances for error would be 
mitigated.  
Finally, this is still a prototype. It is relatively large and is made almost entirely 
out of 3D-printed plastic. The final device should be smaller and manufactured with 
biocompatible materials (initial requirement 2.8).  
4.6 Future work 
At the current stage of the project, we have developed our first fully functional 
prototype and performed preliminary testing in pigs with encouraging results. As the 
trocar is inserted, the pressure cylinder successfully indicates when the cavity is reached, 
most of the time. However, iterations to the device must be made to address the 
limitations previously mentioned. Following that, several tests must be performed to 
show the device fulfills the initial requirements for the project (see Chapter 3). In 
particular, the most important aspect for future development and validation of the device 
is human testing. In addition to testing the abdominal wall insufflation pressure in 
humans, device placement tests must also be performed. At first, these tests may be 
performed in human cadavers. However, eventually, validation tests must be performed 
in live human subjects. To validate the device with initial requirement 1.2, the test 
subjects should have body fat percentages lower than 36% and 26% for females and 
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males, respectively. Furthermore, some validation tests should be performed by field 
medics with basic training to show the device fulfills initial requirement 1.1. 
An improvement to the current device would be to add an automatic stopping 
mechanism. This mechanism could use the movement of the pressure cylinder plunger to 
somehow lock the trocar to prevent it from rotating. This would be an additional safety 
mechanism that would prevent overpenetration into the peritoneal cavity. Another 
improvement would be a quick release of the threaded trocar. It is currently quite 
complicated to detach the trocar from the rest of the placement assembly. The entire case 
must be disassembled, and the center axle and gears removed in order to remove the 
trocar. A quick release would enable a faster disassembly, thus, speeding up the process 
to place the intraperitoneal catheter.  
Also, because the design of this device has been based around tools used for 
laparoscopic surgery, the described device may find application outside the battlefield. 
For instance, the device could be used for placing the primary and/or secondary ports 
during a laparoscopic procedure. Because the device simplifies peritoneal cavity access, 
the primary and secondary ports may even be able to be place by the physician’s 
assistant, prior to the surgeon entering the operating room. If so, the potential market for 
this device would be extremely large.  
4.7 Conclusion 
 For this project, we were able to design, create, and begin testing a new 
intraperitoneal catheter placement device for use on the battlefield. The device uses a 
threaded trocar like the Karl Storz Ternamian EndoTIP to controllably access the 
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peritoneal cavity. It also uses the concept of concomitant insufflation to inform the user 
of the moment the cavity is reached. Since the current design is still just a prototype, 
there are many limitations. However, the device shows promise and has successfully 
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